Benefits of Integrating Medical and Pharmacy Coverage Include Greater Savings, Fewer Trips to the Hospital and ER
New research provided by
The analysis examined 2020 and 2021 data from more than 490,000
Results show that medical costs for members in the integrated model group with Prime as the PBM were nine percent lower than those in a non-integrated model, equating to an average of
In addition to evaluating medical costs, the
"This research validates the true value that members receive when their plan sponsors opt to integrate medical and pharmacy benefits instead of taking a siloed approach," said
Results for members with chronic conditions
Additional analysis took place using member data associated with at least one of ten chronic conditions2, including high blood pressure (hypertension), high cholesterol (hyperlipidemia) and rheumatoid arthritis. The conditions were then categorized as either specialty or non-specialty. The results consistently underscored the cost and health benefits of an integrated model.
Integrated non-specialty chronic conditions
- Medical costs PMPY 14 percent lower
- Hospitalizations 18 percent lower
- Emergency room visits 15 percent lower
Integrated specialty chronic conditions
- Medical costs PMPY 21 percent lower
- Hospitalizations 22 percent lower
- Emergency room visits 13 percent lower
"An integrated approach enables
Methodology details
1 The analysis utilized a limited dataset of PMPY medical cost among 492,565 commercially insured members, divided between 232,894 carve-in members and 259,671 carve-out pharmacy benefit services, continuously enrolled during 2020 through 2021.
Comparisons were between two large self-funded administrative services only (ASO) groups of
Research excluded members with a major change in benefit design (change in medical benefits from or to a consumer directed health plan); a change in insured product type (preferred provider organization to a health maintenance organization); change in pharmacy coverage; or enrollment at any time in a government program (for example, Medicare, Medicaid) during 2020 through 2021.
Differences between groups remained statistically significant when excluding impact of high-cost members with
2 Sub-analyses were performed separately and independently for a total of ten chronic conditions. The eight non-specialty drug conditions of asthma, coronary artery disease (CAD), chronic obstructive pulmonary disease (COPD), congestive heart failure (CHF), depression, Type 2 diabetes mellitus (DM), hypertension (HTN), and lipid storage disorders were assessed as one group. Members with a specialty drug condition of either rheumatoid arthritis (RA) or multiple sclerosis (MS) were assessed as a separate group.
An electronic copy of the full report is available upon request from the media contact at
About
For 90 years,
View original content:https://www.prnewswire.com/news-releases/benefits-of-integrating-medical-and-pharmacy-coverage-include-greater-savings-fewer-trips-to-the-hospital-and-er-301881022.html
SOURCE
Young Insurance Agency Group Joins World Insurance Associates
Industry groups seek relief from some SECURE 2.0 requirements
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News